Hi [[ session.user.profile.firstName ]]
Sort by:
    • Psychosocial Treatments for Generalized Anxiety Disorder Psychosocial Treatments for Generalized Anxiety Disorder Douglas Mennin, PhD, Director of the Yale Anxiety and Mood Services Clinic Recorded: Oct 8 2010 5:00 pm UTC 72 mins
    • Attendees will:
      - Discuss current evidence-based psychotherapeutic treatments for adults with generalized anxiety disorder.
      - Identify characteristics of generalized anxiety disorder.
      - Design a psychosocial treatment plan with patients with GAD.

      Webinar Speaker:
      Douglas Mennin, PhD
      Associate Professor of Psychology, Yale University and Director of the Yale Anxiety and Mood Services Clinic

      Dr. Mennin has focused his research program on understanding and treating chronic and reoccurring bouts of anxiety and mood disorders, particularly worry, stress, and depression. Our understanding of problems related to anxiety and depression has increased exponentially in the past twenty years. Advances in biological and behavioral technologies has helped us shine light on how everyday feelings such as fear and sadness can, in some individuals, translate into emotional disorder.

      Blackwell Futura Media Services designates this educational activity for 1 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity. Blackwell Futura Media Services is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. DETAILS at: http://bit.ly/ADAA_CME2

      Read more >
    • Treating Older Adults with Generalized Anxiety Disorder Treating Older Adults with Generalized Anxiety Disorder Eric Lenze, MD Associate Professor, Department of Psychiatry, Washington University School of Medicine Recorded: Oct 27 2010 5:00 pm UTC 76 mins
    • By 2050 there will be over 150 million older adults with anxiety disorders globally. Symptoms include sleep disturbance, interference with daily activities and distress, which can lead to medical illness such as coronary heart disease, disability, and higher levels of health care utilization.

      Attendees will learn:
      - How anxiety disorders in older adults differ from the disorders in younger adults.
      ~ They can be more detrimental to health and cognition in older adults.
      ~ These disorders may be more treatment-resistant, requiring aggressive treatment such as the combination of medication and psychotherapy.
      - Why late-life anxiety disorders are undetected and undertreated.
      - The benefits of using antidepressants and Cognitive-Behavioral Therapy as safer alternatives to treatment for these disorders in older adults.

      Webinar Speaker:
      Eric Lenze, MD
      Associate Professor, Department of Psychiatry, Washington University School of Medicine

      Dr. Lenze completed medical school and psychiatry residency at Washington University School of Medicine. He trained in a geriatric psychiatry fellowship and a clinical research fellowship at University of Pittsburgh, then joined the faculty, as part of the Advanced Center for Interventions and Services Research in Late-life mood disorders. In 2007, he returned to Washington University to focus on treatment studies in late-life anxiety disorders and depression. He carries out clinical research in disabled rehabilitating elderly populations and runs a faculty practice treating late-life anxiety disorders and depression.

      Blackwell Futura Media Services designates this educational activity for 1 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity. Blackwell Futura Media Services is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. DETAILS at: http://bit.ly/adaa_cme4

      Read more >
    • Understanding & Treating Generalized Anxiety Disorder Understanding & Treating Generalized Anxiety Disorder Mark Pollack, MD, Director, Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital Recorded: Sep 21 2010 7:00 pm UTC 77 mins
    • Attendees will:
      - discuss the neurobiology of GAD
      - recognize symptoms and diagnose individuals with generalized anxiety disorder
      - plan evidence-based treatment for individuals with GAD and gad and comorbid disorders including depression, sleep disorders, cardiac illnesses and IBS.

      Webinar speaker:
      Mark Pollack, MD, Director, Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital
      Professor of Psychiatry, Harvard Medical School

      Dr. Pollack’s areas of clinical and research interest include the acute and long-term course, pathophysiology, and treatment of patients with anxiety disorders and associated comorbidities, development of novel pharmacologic agents for mood and anxiety disorders, uses of combined cognitive-behavioral and pharmacologic therapies for treatment refractory patients, presentation and treatment of anxiety in the medical setting, and the pathophysiology and treatment of substance abuse.

      Blackwell Futura Media Services designates this educational activity for 1 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity. Blackwell Futura Media Services is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. DETAILS at: http://bit.ly/ADAA_CME1

      Read more >
    • Business Continuity Business Continuity Socrates Coudounaris (IRM Board Member) Recorded: Sep 29 2015 10:00 am UTC 45 mins
    • Business continuity encompasses a loosely defined set of planning, preparatory and related activities which are intended to ensure that an organization's critical business functions will either continue to operate despite serious incidents or disasters that might otherwise have interrupted them, or will be recovered to an operational state within a reasonably short period. As such, business continuity includes three key elements: 1. Resilience: critical business functions and the supporting infrastructure are designed and engineered in such a way that they are materially unaffected by most disruptions, for example through the use of redundancy and spare capacity; 2. Recovery: arrangements are made to recover or restore critical and less critical business functions that fail for some reason. 3. Contingency: the organization establishes a generalized capability and readiness to cope effectively with whatever major incidents and disasters occur, including those that were not, and perhaps could not have been, foreseen. Contingency preparations constitute a last-resort response if resilience and recovery arrangements should prove inadequate in practice.

      Read more >
    • Security Lessons Learned from Target, Niemen Marcus, Sony and Other Breaches Security Lessons Learned from Target, Niemen Marcus, Sony and Other Breaches Randy Franklin Smith: Windows Security Subject Matter Expert; Erick Ingleby: Product Manager, LogRhythm, Inc. Recorded: Jul 28 2015 3:00 pm UTC 98 mins
    • With major data breaches on the rise, it’s hard to deny that they've become a common occurrence in the security threat landscape. Large companies such as Target, Nieman Marcus and Sony (among others), have suffered major data breaches in the past year.

      As security professional, it is important to understand why and how these organizations were breached so you can learn from what was done right, what worked and what didn’t.

      In this webinar, Randy Franklin Smith, Windows Security Subject Matter Expert, and Erik Ingleby, Product Manager at LogRhythm, will discuss lessons learned from recent breaches. By analyzing the available information about recent data breach incidents from the perspective of detection, Smith and Ingleby have assembled a list of security monitoring lessons and ideas.

      You’ll get tips on how to eliminate double false positives, a number of generalized monitoring scenarios and guidelines on how to monitor for new executables running for the first time on your environment.

      Read more >
    • Treating GAD in Primary Care Settings Treating GAD in Primary Care Settings Larry Culpepper, MD, MPH Professor and Chairman, Department of Family Medicine, Boston University Recorded: Oct 13 2010 5:00 pm UTC 78 mins
    • Attendees will:
      - recognize symptoms of Generalized Anxiety Disorder in primary care patients
      - use current pharmacological and psychotherapeutic treatments to develop a management plan
      - assess different treatments for comorbid GAD and refractory cases

      Webinar Speaker:
      Larry Culpepper, MD, MPH
      Professor of Family Medicine and Chairman, Department of Family Medicine, Boston University

      Dr. Culpepper has conducted federally funded studies of depression and anxiety, otitis media, and school-based and community interventions to improve pregnancy outcomes and to prevent teen pregnancies. He currently is the principal investigator of an AHRQ funded developmental center for patient safety research devoted to the study of problems affecting low income and minority vulnerable populations in ambulatory care settings, and co-investigator of the Primary Care Anxiety Project, a study of the course of anxiety disorders in primary care settings.

      Dr. Culpepper also is Chief of Family Practice at Boston Medical Center. He received his MD degree from Baylor College of Medicine and his MPH degree from Boston University.

      Blackwell Futura Media Services designates this educational activity for 1 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity. Blackwell Futura Media Services is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. DETAILS at: http://bit.ly/adaa_cme3

      Read more >
    • Cross-channel personalization: Are you losing customers? Cross-channel personalization: Are you losing customers? Andrew Jones, Insight Analyst, VentureBeat Recorded: Nov 19 2015 6:00 pm UTC 62 mins
    • Editorial VB Insight webinar sponsored by Boomtrain

      Do you create the most relevant messages and experience possible for your customers? How's your accuracy?

      Or do they see generalized messages and offers that may be completely different depending on whether they engage with your company via ads, email, website, or your mobile app?

      Consumers are tuning out noise — unsubscribing from email, turning off notifications, blocking ads — and are increasingly expecting and engaging with personalized content. What's more, they're incredibly intolerant of mistakes and errors -- a recent study found that upon finding an error in personalized messaging, 16% would consider a competitor's business and 13% would immediately abandon the transaction all together. Yikes.

      In short, personalization is critical to the success of modern marketers, yet few are doing a good job today -- and are hemorrhaging customers without even realizing it.

      We'll help you not only understand who customers are, and how to personalize their experiences. By attending this webinar you'll:

      •Learn how to collect the right customer identity data
      •Benchmark according to what your peers are doing today
      •Objectives most commonly associated with personalization
      •Best practices for engaging customers across channels
      •Where in the funnel personalization can help most

      Speakers:
      Andrew Jones, analyst, VB Insight, VentureBeat
      Cate Twohill, Senior director and managing partner of CRM services, WGBH, Boston
      Brian Witlin, COO, Yummly
      Wendy Schuchart, moderator, VentureBeat


      Check out VB Insight to access Andrew's Personalization research, and to access the latest research on Marketing Technology: http://insight.venturebeat.com

      Read more >
    • The Smith Chart The Smith Chart Bill Williamson Recorded: Sep 19 2013 3:00 pm UTC 32 mins
    • The Smith chart, invented by Phillip H. Smith (1905–1987), is a graphical designed for electrical and electronics engineers specializing in radio frequency (RF) engineering to assist in solving problems with transmission lines and matching circuits. An article appeared in the January, 1939 issue of Electronics that changed forever the way radio engineers think about transmission lines. Phil Smith devised an extraordinarily clever circular chart that revealed graphically the complex impedance anywhere along a line.
      This webinar is designed to introduce young RF engineers who may never have heard of the Smith chart to its immense power. We all use it unknowingly every day when because it is built in to so many systems that we do not even know it is there.
      The chart is simply the unit circle of the complex plane representing the generalized reflection coefficient. The contours representing constant real and imaginary line impedances are overlaid . Thus, the chart can be used to directly determine the normalized line impedance at any position of the transmission line as well as the reflection coefficient. The chart is also a unit’s converter. No mathematics are needed because all quantities are simply determined graphically. So ingenious was his invention that it has been the standard of the industry - for nearly sixty years.
      I am going to show you just how simple it is to design a balun to match a transmission line to an antenna.

      PLEASE NOTE: Please be sure to leave your correct email address when registering as you will be sent a copy of The Smith Chart for this exercise. You will also need a pencil, 12" ruler and compass/divider.

      I hope you enjoy the exercise.

      Read more >
    • GAD and Cormorbidity:  Impact on Patient Health GAD and Cormorbidity: Impact on Patient Health Dr. Naomi M. Simon, Associate Director of the Center for Anxiety and Traumatic Stress Disorders Recorded: Nov 9 2010 5:00 pm UTC 66 mins
    • Generalized Anxiety Disorder (GAD) is common, chronic, and associated with substantial impairment in function and quality of life. GAD commonly occurs comorbid with mood disorders and anxiety disorders. GAD comorbidity has been clearly linked to additive worsening of outcomes and function in both Major Depressive Disorder and in Bipolar Disorder. This presentation will provide an update on current understandings about the incidence and nature of GAD and comorbid disorders, and their impact on patient health.

      During this webinar attendees will:

      1) Understand the overlap of Generalized Anxiety Disorder (GAD) with mood disorders

      2) Understand the impact of GAD comorbidity on severity of illness including suicidality, quality of life and functioning in individuals with GAD

      3) Learn about the need to address GAD and its comorbidities to optimally improve patient health

      Naomi Michele Simon, M.D., M.Sc.

      Dr. Naomi M. Simon is Associate Director of the Center for Anxiety and Traumatic Stress Disorders and Director of the recently established Complicated Grief Program at Massachusetts General Hospital, and is Associate Professor of Psychiatry, Harvard Medical School.

      Blackwell Futura Media Services designates this educational activity for 1 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity. Blackwell Futura Media Services is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. DETAILS at: http://bit.ly/ADAA_CME5

      Read more >
    • On the Creation of a Micro Grid to Enable Smart Grid On the Creation of a Micro Grid to Enable Smart Grid Dr. Rajit Gadh, Director, UCLA-WINMEC Recorded: Jul 12 2011 6:00 pm UTC 48 mins
    • The talk will present a fundamentally new approach that creates a generalized convergence of communications with information technology to result in the UCLA WINSmartGridTM (Wireless Internet Smart Grid http://winmec.ucla.edu/smartgrid). The technological approach, WINSmartGridTM, presents a converged approach for real-time monitoring within residential, commercial or industrial sectors. Its architecture supports multiple wireless protocols and works with various sensors such as temperature, humidity, shock, motion, etc., to monitor necessary versus unnecessary consumption. Its embedded capability controls appliances wirelessly and/or controls reverse-fills electrical power from electric vehicles. Its architecture enables renewable energy sources such as solar PVC with stand-alone batteries or aggregate EVs to be integrated within a micro-grid in a campus setting such as UCLA. A micro-grid campus demonstration is being developed within UCLA’s school of engineering as part of the Smart Grid Energy Research Center (http://smartgrid.ucla.edu) or SMERC.

      UCLA is a participant in DOE’s Smart Grid ARRA funding and is working on developing within SMERC and with its collaborators, the underlying foundational technologies that would go into solving problems such as Automated Demand Response, EV Integration (G2V and V2G), Cyber-security, renewable integration architecture, and, integration of community storage within a Microgrid. These demonstrations will be held within UCLA and their scalability will be studied. The talk will discuss the research and technological developments in these ongoing demonstration activities.

      Read more >
    • GAD and Substance Abuse GAD and Substance Abuse Dr. Susan Sonne, Associate Professor of Psychiatry and Pharmacy at the Medical University of South Carolina Recorded: Nov 23 2010 4:00 pm UTC 70 mins
    • Substance use disorders commonly co-occur with anxiety disorders. Diagnosing anxiety disorders in the face of active substance use and withdrawal can be very challenging due to the significant symptom overlap. This symptom overlap often leads to delayed or inadequate treatment. When treating individuals with generalized anxiety disorder and a substance use disorder, benzodiazepines should be avoided. Selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors are FDA-approved to treat GAD and are fairly safe in substance users. Other non-FDA approved medications will also be discussed.

      During this webinar, attendees will learn:

      -What symptoms of anxiety overlap with substance use and withdrawal

      - How to diagnose anxiety disorders in the face of substance use

      -Why substance abuse and anxiety disorders co-occur so frequently

      -How to treat individuals with anxiety disorders and comorbid substance abuse

      Dr. Susan Sonne is active in research and teaching as Associate Professor of Psychiatry and Pharmacy at the Medical University of South Carolina, Department of Psychiatry and Behavioral Sciences, Clinical Neuroscience Division.

      Blackwell Futura Media Services designates this educational activity for 1 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity. Blackwell Futura Media Services is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. DETAILS at: http://bit.ly/adaa_cme6

      Read more >